nodes	percent_of_prediction	percent_of_DWPC	metapath
Prasugrel—CES2—Mycophenolate mofetil—psoriasis	0.445	0.539	CbGbCtD
Prasugrel—ALB—Acitretin—psoriasis	0.0622	0.0753	CbGbCtD
Prasugrel—CYP2B6—Cholecalciferol—psoriasis	0.0342	0.0415	CbGbCtD
Prasugrel—ALB—Mycophenolate mofetil—psoriasis	0.0291	0.0352	CbGbCtD
Prasugrel—ALB—Prednisone—psoriasis	0.0233	0.0282	CbGbCtD
Prasugrel—CYP2C19—Cholecalciferol—psoriasis	0.0218	0.0264	CbGbCtD
Prasugrel—CYP3A4—Calcitriol—psoriasis	0.0204	0.0247	CbGbCtD
Prasugrel—CYP2C9—Cholecalciferol—psoriasis	0.0181	0.0219	CbGbCtD
Prasugrel—CYP3A4—Methoxsalen—psoriasis	0.0159	0.0192	CbGbCtD
Prasugrel—CYP2C19—Prednisone—psoriasis	0.0151	0.0183	CbGbCtD
Prasugrel—CYP2B6—Dexamethasone—psoriasis	0.0148	0.0179	CbGbCtD
Prasugrel—CYP2C19—Cyclosporine—psoriasis	0.0143	0.0173	CbGbCtD
Prasugrel—CYP2C9—Cyclosporine—psoriasis	0.0119	0.0144	CbGbCtD
Prasugrel—ALB—Methotrexate—psoriasis	0.0117	0.0141	CbGbCtD
Prasugrel—CYP3A4—Cholecalciferol—psoriasis	0.0105	0.0127	CbGbCtD
Prasugrel—CYP2C19—Dexamethasone—psoriasis	0.00942	0.0114	CbGbCtD
Prasugrel—CYP3A4—Triamcinolone—psoriasis	0.00912	0.011	CbGbCtD
Prasugrel—CYP3A4—Mycophenolate mofetil—psoriasis	0.00912	0.011	CbGbCtD
Prasugrel—CYP2C9—Dexamethasone—psoriasis	0.00783	0.00948	CbGbCtD
Prasugrel—CYP3A4—Betamethasone—psoriasis	0.00782	0.00948	CbGbCtD
Prasugrel—CYP3A4—Prednisolone—psoriasis	0.00772	0.00935	CbGbCtD
Prasugrel—CYP3A4—Hydrocortisone—psoriasis	0.00732	0.00887	CbGbCtD
Prasugrel—CYP3A4—Prednisone—psoriasis	0.00729	0.00883	CbGbCtD
Prasugrel—CYP3A4—Cyclosporine—psoriasis	0.00691	0.00837	CbGbCtD
Prasugrel—CYP3A4—Dexamethasone—psoriasis	0.00455	0.00551	CbGbCtD
Prasugrel—CYP2B6—CYP2E1 reactions—CYP2S1—psoriasis	0.00131	0.0806	CbGpPWpGaD
Prasugrel—CYP2C19—CYP2E1 reactions—CYP2S1—psoriasis	0.000991	0.0609	CbGpPWpGaD
Prasugrel—CYP2C9—CYP2E1 reactions—CYP2S1—psoriasis	0.000903	0.0555	CbGpPWpGaD
Prasugrel—CYP2B6—Xenobiotics—CYP2S1—psoriasis	0.000813	0.05	CbGpPWpGaD
Prasugrel—CYP2C19—Xenobiotics—CYP2S1—psoriasis	0.000614	0.0378	CbGpPWpGaD
Prasugrel—CYP2C9—Xenobiotics—CYP2S1—psoriasis	0.00056	0.0344	CbGpPWpGaD
Prasugrel—CES2—NRF2 pathway—TGFA—psoriasis	0.000473	0.0291	CbGpPWpGaD
Prasugrel—P2RY12—G alpha (i) signalling events—HCAR2—psoriasis	0.000424	0.0261	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—SERPINB8—psoriasis	0.000379	0.0233	CbGpPWpGaD
Prasugrel—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.000369	0.0227	CbGpPWpGaD
Prasugrel—P2RY12—Class A/1 (Rhodopsin-like receptors)—HCAR2—psoriasis	0.000338	0.0208	CbGpPWpGaD
Prasugrel—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000337	0.0207	CbGpPWpGaD
Prasugrel—CYP2B6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000333	0.0205	CbGpPWpGaD
Prasugrel—Hypersensitivity—Fluocinolone Acetonide—psoriasis	0.000314	0.00198	CcSEcCtD
Prasugrel—Haemoglobin—Mycophenolate mofetil—psoriasis	0.000313	0.00198	CcSEcCtD
Prasugrel—Urethral disorder—Cyclosporine—psoriasis	0.000313	0.00198	CcSEcCtD
Prasugrel—Haemorrhage—Mycophenolate mofetil—psoriasis	0.000312	0.00197	CcSEcCtD
Prasugrel—Urinary tract disorder—Mycophenolate mofetil—psoriasis	0.000308	0.00195	CcSEcCtD
Prasugrel—Leukopenia—Mycophenolic acid—psoriasis	0.000308	0.00195	CcSEcCtD
Prasugrel—Oedema peripheral—Mycophenolate mofetil—psoriasis	0.000307	0.00194	CcSEcCtD
Prasugrel—Asthenia—Acitretin—psoriasis	0.000306	0.00194	CcSEcCtD
Prasugrel—Urethral disorder—Mycophenolate mofetil—psoriasis	0.000306	0.00193	CcSEcCtD
Prasugrel—Gastrointestinal haemorrhage—Prednisone—psoriasis	0.000306	0.00193	CcSEcCtD
Prasugrel—CES2—Fluoropyrimidine Activity—TP53—psoriasis	0.000303	0.0186	CbGpPWpGaD
Prasugrel—Rash—Calcitriol—psoriasis	0.000303	0.00191	CcSEcCtD
Prasugrel—Dermatitis—Calcitriol—psoriasis	0.000302	0.00191	CcSEcCtD
Prasugrel—Headache—Calcitriol—psoriasis	0.000301	0.0019	CcSEcCtD
Prasugrel—Cough—Mycophenolic acid—psoriasis	0.0003	0.0019	CcSEcCtD
Prasugrel—Dyspnoea—Hydroxyurea—psoriasis	0.000299	0.00189	CcSEcCtD
Prasugrel—Hypertension—Mycophenolic acid—psoriasis	0.000297	0.00188	CcSEcCtD
Prasugrel—Bradycardia—Prednisolone—psoriasis	0.000296	0.00187	CcSEcCtD
Prasugrel—Haemoglobin—Prednisolone—psoriasis	0.000292	0.00185	CcSEcCtD
Prasugrel—Diarrhoea—Acitretin—psoriasis	0.000292	0.00185	CcSEcCtD
Prasugrel—Eye disorder—Mycophenolate mofetil—psoriasis	0.000291	0.00184	CcSEcCtD
Prasugrel—Diarrhoea—Fluocinolone Acetonide—psoriasis	0.000291	0.00184	CcSEcCtD
Prasugrel—Haemorrhage—Prednisolone—psoriasis	0.000291	0.00184	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—psoriasis	0.000291	0.00184	CcSEcCtD
Prasugrel—Angiopathy—Cyclosporine—psoriasis	0.00029	0.00183	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Hydroxyurea—psoriasis	0.000289	0.00183	CcSEcCtD
Prasugrel—Bradycardia—Hydrocortisone—psoriasis	0.000289	0.00183	CcSEcCtD
Prasugrel—Fatigue—Hydroxyurea—psoriasis	0.000289	0.00183	CcSEcCtD
Prasugrel—Mediastinal disorder—Cyclosporine—psoriasis	0.000288	0.00182	CcSEcCtD
Prasugrel—Haemoglobin—Hydrocortisone—psoriasis	0.000286	0.00181	CcSEcCtD
Prasugrel—Nausea—Calcitriol—psoriasis	0.000285	0.0018	CcSEcCtD
Prasugrel—Haemorrhage—Hydrocortisone—psoriasis	0.000284	0.0018	CcSEcCtD
Prasugrel—Angiopathy—Mycophenolate mofetil—psoriasis	0.000283	0.00179	CcSEcCtD
Prasugrel—Dizziness—Acitretin—psoriasis	0.000282	0.00178	CcSEcCtD
Prasugrel—Dizziness—Fluocinolone Acetonide—psoriasis	0.000282	0.00178	CcSEcCtD
Prasugrel—Epistaxis—Triamcinolone—psoriasis	0.000281	0.00178	CcSEcCtD
Prasugrel—Mediastinal disorder—Mycophenolate mofetil—psoriasis	0.000281	0.00178	CcSEcCtD
Prasugrel—Thrombocytopenia—Mycophenolic acid—psoriasis	0.000275	0.00174	CcSEcCtD
Prasugrel—CYP2B6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000274	0.0168	CbGpPWpGaD
Prasugrel—Skin disorder—Mycophenolic acid—psoriasis	0.000273	0.00172	CcSEcCtD
Prasugrel—Bradycardia—Triamcinolone—psoriasis	0.000272	0.00172	CcSEcCtD
Prasugrel—Rash—Acitretin—psoriasis	0.000269	0.0017	CcSEcCtD
Prasugrel—Dermatitis—Acitretin—psoriasis	0.000269	0.0017	CcSEcCtD
Prasugrel—Haemoglobin—Triamcinolone—psoriasis	0.000269	0.0017	CcSEcCtD
Prasugrel—Rash—Fluocinolone Acetonide—psoriasis	0.000268	0.0017	CcSEcCtD
Prasugrel—Dermatitis—Fluocinolone Acetonide—psoriasis	0.000268	0.0017	CcSEcCtD
Prasugrel—Haemorrhage—Triamcinolone—psoriasis	0.000268	0.00169	CcSEcCtD
Prasugrel—Headache—Acitretin—psoriasis	0.000267	0.00169	CcSEcCtD
Prasugrel—Headache—Fluocinolone Acetonide—psoriasis	0.000267	0.00169	CcSEcCtD
Prasugrel—Eye disorder—Hydrocortisone—psoriasis	0.000265	0.00168	CcSEcCtD
Prasugrel—Body temperature increased—Hydroxyurea—psoriasis	0.000265	0.00168	CcSEcCtD
Prasugrel—Back pain—Mycophenolate mofetil—psoriasis	0.000263	0.00166	CcSEcCtD
Prasugrel—Hypotension—Mycophenolic acid—psoriasis	0.000262	0.00166	CcSEcCtD
Prasugrel—Cerebrovascular accident—Methotrexate—psoriasis	0.000261	0.00165	CcSEcCtD
Prasugrel—Anaemia—Cyclosporine—psoriasis	0.000257	0.00163	CcSEcCtD
Prasugrel—P2RY12—GPCR ligand binding—HCAR2—psoriasis	0.000257	0.0158	CbGpPWpGaD
Prasugrel—Immune system disorder—Hydrocortisone—psoriasis	0.000257	0.00162	CcSEcCtD
Prasugrel—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000255	0.0157	CbGpPWpGaD
Prasugrel—Angioedema—Cyclosporine—psoriasis	0.000254	0.00161	CcSEcCtD
Prasugrel—Nausea—Acitretin—psoriasis	0.000254	0.0016	CcSEcCtD
Prasugrel—Nausea—Fluocinolone Acetonide—psoriasis	0.000253	0.0016	CcSEcCtD
Prasugrel—CYP2C19—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000252	0.0155	CbGpPWpGaD
Prasugrel—Anaemia—Mycophenolate mofetil—psoriasis	0.000251	0.00159	CcSEcCtD
Prasugrel—Dyspnoea—Mycophenolic acid—psoriasis	0.00025	0.00158	CcSEcCtD
Prasugrel—Leukopenia—Cyclosporine—psoriasis	0.000249	0.00157	CcSEcCtD
Prasugrel—Angioedema—Mycophenolate mofetil—psoriasis	0.000248	0.00157	CcSEcCtD
Prasugrel—Bradycardia—Dexamethasone—psoriasis	0.000247	0.00156	CcSEcCtD
Prasugrel—Bradycardia—Betamethasone—psoriasis	0.000247	0.00156	CcSEcCtD
Prasugrel—Hypersensitivity—Hydroxyurea—psoriasis	0.000247	0.00156	CcSEcCtD
Prasugrel—Haemoglobin—Dexamethasone—psoriasis	0.000244	0.00154	CcSEcCtD
Prasugrel—Haemoglobin—Betamethasone—psoriasis	0.000244	0.00154	CcSEcCtD
Prasugrel—Leukopenia—Mycophenolate mofetil—psoriasis	0.000243	0.00154	CcSEcCtD
Prasugrel—Cough—Cyclosporine—psoriasis	0.000243	0.00154	CcSEcCtD
Prasugrel—Haemorrhage—Dexamethasone—psoriasis	0.000243	0.00153	CcSEcCtD
Prasugrel—Haemorrhage—Betamethasone—psoriasis	0.000243	0.00153	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Mycophenolic acid—psoriasis	0.000242	0.00153	CcSEcCtD
Prasugrel—Fatigue—Mycophenolic acid—psoriasis	0.000242	0.00153	CcSEcCtD
Prasugrel—Asthenia—Hydroxyurea—psoriasis	0.00024	0.00152	CcSEcCtD
Prasugrel—Hypertension—Cyclosporine—psoriasis	0.00024	0.00152	CcSEcCtD
Prasugrel—Cough—Mycophenolate mofetil—psoriasis	0.000237	0.0015	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—psoriasis	0.000235	0.00149	CcSEcCtD
Prasugrel—Hypertension—Mycophenolate mofetil—psoriasis	0.000234	0.00148	CcSEcCtD
Prasugrel—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000232	0.0143	CbGpPWpGaD
Prasugrel—Angioedema—Prednisolone—psoriasis	0.000231	0.00146	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—psoriasis	0.00023	0.00145	CcSEcCtD
Prasugrel—CYP2C9—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000229	0.0141	CbGpPWpGaD
Prasugrel—Diarrhoea—Hydroxyurea—psoriasis	0.000229	0.00145	CcSEcCtD
Prasugrel—Anaphylactic shock—Cyclosporine—psoriasis	0.000227	0.00144	CcSEcCtD
Prasugrel—Eye disorder—Dexamethasone—psoriasis	0.000227	0.00143	CcSEcCtD
Prasugrel—Eye disorder—Betamethasone—psoriasis	0.000227	0.00143	CcSEcCtD
Prasugrel—Angioedema—Hydrocortisone—psoriasis	0.000226	0.00143	CcSEcCtD
Prasugrel—Back pain—Triamcinolone—psoriasis	0.000225	0.00142	CcSEcCtD
Prasugrel—Thrombocytopenia—Cyclosporine—psoriasis	0.000222	0.00141	CcSEcCtD
Prasugrel—Body temperature increased—Mycophenolic acid—psoriasis	0.000222	0.0014	CcSEcCtD
Prasugrel—Dizziness—Hydroxyurea—psoriasis	0.000222	0.0014	CcSEcCtD
Prasugrel—Anaphylactic shock—Mycophenolate mofetil—psoriasis	0.000222	0.0014	CcSEcCtD
Prasugrel—Skin disorder—Cyclosporine—psoriasis	0.000221	0.00139	CcSEcCtD
Prasugrel—P2RY12—G alpha (i) signalling events—CCL20—psoriasis	0.00022	0.0136	CbGpPWpGaD
Prasugrel—Angiopathy—Betamethasone—psoriasis	0.00022	0.00139	CcSEcCtD
Prasugrel—Angiopathy—Dexamethasone—psoriasis	0.00022	0.00139	CcSEcCtD
Prasugrel—Hypertension—Prednisolone—psoriasis	0.000219	0.00138	CcSEcCtD
Prasugrel—Thrombocytopenia—Mycophenolate mofetil—psoriasis	0.000217	0.00137	CcSEcCtD
Prasugrel—Skin disorder—Mycophenolate mofetil—psoriasis	0.000215	0.00136	CcSEcCtD
Prasugrel—Bradycardia—Prednisone—psoriasis	0.000215	0.00136	CcSEcCtD
Prasugrel—Hypertension—Hydrocortisone—psoriasis	0.000214	0.00135	CcSEcCtD
Prasugrel—Angioedema—Triamcinolone—psoriasis	0.000213	0.00135	CcSEcCtD
Prasugrel—Haemoglobin—Prednisone—psoriasis	0.000212	0.00134	CcSEcCtD
Prasugrel—Haemorrhage—Prednisone—psoriasis	0.000211	0.00134	CcSEcCtD
Prasugrel—Rash—Hydroxyurea—psoriasis	0.000211	0.00134	CcSEcCtD
Prasugrel—Dermatitis—Hydroxyurea—psoriasis	0.000211	0.00133	CcSEcCtD
Prasugrel—Headache—Hydroxyurea—psoriasis	0.00021	0.00133	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—psoriasis	0.000209	0.00132	CcSEcCtD
Prasugrel—Hypotension—Mycophenolate mofetil—psoriasis	0.000207	0.00131	CcSEcCtD
Prasugrel—CYP2C19—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000207	0.0127	CbGpPWpGaD
Prasugrel—Anaphylactic shock—Prednisolone—psoriasis	0.000207	0.00131	CcSEcCtD
Prasugrel—Cough—Triamcinolone—psoriasis	0.000203	0.00128	CcSEcCtD
Prasugrel—Dyspnoea—Cyclosporine—psoriasis	0.000202	0.00128	CcSEcCtD
Prasugrel—Anaphylactic shock—Hydrocortisone—psoriasis	0.000202	0.00128	CcSEcCtD
Prasugrel—Asthenia—Mycophenolic acid—psoriasis	0.000201	0.00127	CcSEcCtD
Prasugrel—Hypertension—Triamcinolone—psoriasis	0.000201	0.00127	CcSEcCtD
Prasugrel—ALB—HDL-mediated lipid transport—APOE—psoriasis	0.000201	0.0124	CbGpPWpGaD
Prasugrel—Nausea—Hydroxyurea—psoriasis	0.000199	0.00126	CcSEcCtD
Prasugrel—Eye disorder—Prednisone—psoriasis	0.000198	0.00125	CcSEcCtD
Prasugrel—Dyspnoea—Mycophenolate mofetil—psoriasis	0.000198	0.00125	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000196	0.00124	CcSEcCtD
Prasugrel—Skin disorder—Hydrocortisone—psoriasis	0.000196	0.00124	CcSEcCtD
Prasugrel—Fatigue—Cyclosporine—psoriasis	0.000196	0.00124	CcSEcCtD
Prasugrel—Angioedema—Betamethasone—psoriasis	0.000193	0.00122	CcSEcCtD
Prasugrel—Angioedema—Dexamethasone—psoriasis	0.000193	0.00122	CcSEcCtD
Prasugrel—Diarrhoea—Mycophenolic acid—psoriasis	0.000192	0.00121	CcSEcCtD
Prasugrel—Angiopathy—Prednisone—psoriasis	0.000192	0.00121	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000191	0.00121	CcSEcCtD
Prasugrel—Immune system disorder—Prednisone—psoriasis	0.000191	0.00121	CcSEcCtD
Prasugrel—Anaphylactic shock—Triamcinolone—psoriasis	0.00019	0.0012	CcSEcCtD
Prasugrel—Hypotension—Hydrocortisone—psoriasis	0.000189	0.00119	CcSEcCtD
Prasugrel—CYP2C9—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000188	0.0116	CbGpPWpGaD
Prasugrel—Haematuria—Methotrexate—psoriasis	0.000188	0.00119	CcSEcCtD
Prasugrel—Dizziness—Mycophenolic acid—psoriasis	0.000186	0.00117	CcSEcCtD
Prasugrel—Epistaxis—Methotrexate—psoriasis	0.000186	0.00117	CcSEcCtD
Prasugrel—Hypertension—Dexamethasone—psoriasis	0.000182	0.00115	CcSEcCtD
Prasugrel—Hypertension—Betamethasone—psoriasis	0.000182	0.00115	CcSEcCtD
Prasugrel—Body temperature increased—Cyclosporine—psoriasis	0.00018	0.00113	CcSEcCtD
Prasugrel—Haemoglobin—Methotrexate—psoriasis	0.000178	0.00112	CcSEcCtD
Prasugrel—Rash—Mycophenolic acid—psoriasis	0.000177	0.00112	CcSEcCtD
Prasugrel—Dermatitis—Mycophenolic acid—psoriasis	0.000177	0.00112	CcSEcCtD
Prasugrel—Haemorrhage—Methotrexate—psoriasis	0.000177	0.00112	CcSEcCtD
Prasugrel—Headache—Mycophenolic acid—psoriasis	0.000176	0.00111	CcSEcCtD
Prasugrel—P2RY12—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	0.000175	0.0108	CbGpPWpGaD
Prasugrel—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000175	0.00111	CcSEcCtD
Prasugrel—Urinary tract disorder—Methotrexate—psoriasis	0.000174	0.0011	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000174	0.0011	CcSEcCtD
Prasugrel—Fatigue—Hydrocortisone—psoriasis	0.000174	0.0011	CcSEcCtD
Prasugrel—Urethral disorder—Methotrexate—psoriasis	0.000173	0.00109	CcSEcCtD
Prasugrel—Anaphylactic shock—Dexamethasone—psoriasis	0.000172	0.00109	CcSEcCtD
Prasugrel—Anaphylactic shock—Betamethasone—psoriasis	0.000172	0.00109	CcSEcCtD
Prasugrel—Anaemia—Prednisone—psoriasis	0.00017	0.00108	CcSEcCtD
Prasugrel—Dyspnoea—Triamcinolone—psoriasis	0.000169	0.00107	CcSEcCtD
Prasugrel—Thrombocytopenia—Betamethasone—psoriasis	0.000169	0.00107	CcSEcCtD
Prasugrel—Thrombocytopenia—Dexamethasone—psoriasis	0.000169	0.00107	CcSEcCtD
Prasugrel—Angioedema—Prednisone—psoriasis	0.000168	0.00106	CcSEcCtD
Prasugrel—Hypersensitivity—Cyclosporine—psoriasis	0.000167	0.00106	CcSEcCtD
Prasugrel—Nausea—Mycophenolic acid—psoriasis	0.000167	0.00105	CcSEcCtD
Prasugrel—Eye disorder—Methotrexate—psoriasis	0.000165	0.00104	CcSEcCtD
Prasugrel—Fatigue—Triamcinolone—psoriasis	0.000164	0.00104	CcSEcCtD
Prasugrel—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000163	0.00103	CcSEcCtD
Prasugrel—Asthenia—Cyclosporine—psoriasis	0.000163	0.00103	CcSEcCtD
Prasugrel—Hypotension—Betamethasone—psoriasis	0.000161	0.00102	CcSEcCtD
Prasugrel—Hypotension—Dexamethasone—psoriasis	0.000161	0.00102	CcSEcCtD
Prasugrel—Angiopathy—Methotrexate—psoriasis	0.00016	0.00101	CcSEcCtD
Prasugrel—Immune system disorder—Methotrexate—psoriasis	0.00016	0.00101	CcSEcCtD
Prasugrel—Body temperature increased—Hydrocortisone—psoriasis	0.00016	0.00101	CcSEcCtD
Prasugrel—Mediastinal disorder—Methotrexate—psoriasis	0.000159	0.00101	CcSEcCtD
Prasugrel—Asthenia—Mycophenolate mofetil—psoriasis	0.000159	0.001	CcSEcCtD
Prasugrel—Hypertension—Prednisone—psoriasis	0.000159	0.001	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.000156	0.000984	CcSEcCtD
Prasugrel—Diarrhoea—Cyclosporine—psoriasis	0.000155	0.000982	CcSEcCtD
Prasugrel—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000155	0.00953	CbGpPWpGaD
Prasugrel—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000153	0.00943	CbGpPWpGaD
Prasugrel—Hypersensitivity—Prednisolone—psoriasis	0.000152	0.000963	CcSEcCtD
Prasugrel—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000152	0.000958	CcSEcCtD
Prasugrel—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000151	0.0093	CbGpPWpGaD
Prasugrel—Body temperature increased—Triamcinolone—psoriasis	0.00015	0.00095	CcSEcCtD
Prasugrel—Dizziness—Cyclosporine—psoriasis	0.00015	0.000949	CcSEcCtD
Prasugrel—Anaphylactic shock—Prednisone—psoriasis	0.00015	0.000949	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000149	0.000941	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Betamethasone—psoriasis	0.000149	0.000941	CcSEcCtD
Prasugrel—Back pain—Methotrexate—psoriasis	0.000149	0.00094	CcSEcCtD
Prasugrel—Hypersensitivity—Hydrocortisone—psoriasis	0.000149	0.00094	CcSEcCtD
Prasugrel—Fatigue—Dexamethasone—psoriasis	0.000149	0.00094	CcSEcCtD
Prasugrel—Fatigue—Betamethasone—psoriasis	0.000149	0.00094	CcSEcCtD
Prasugrel—Dizziness—Mycophenolate mofetil—psoriasis	0.000147	0.000926	CcSEcCtD
Prasugrel—Skin disorder—Prednisone—psoriasis	0.000146	0.000922	CcSEcCtD
Prasugrel—CYP2B6—Biological oxidations—CYP2S1—psoriasis	0.000145	0.00893	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—HCAR2—psoriasis	0.000145	0.00893	CbGpPWpGaD
Prasugrel—Asthenia—Hydrocortisone—psoriasis	0.000145	0.000915	CcSEcCtD
Prasugrel—CYP2B6—Metapathway biotransformation—CYP2S1—psoriasis	0.000143	0.00881	CbGpPWpGaD
Prasugrel—Rash—Cyclosporine—psoriasis	0.000143	0.000905	CcSEcCtD
Prasugrel—Dermatitis—Cyclosporine—psoriasis	0.000143	0.000904	CcSEcCtD
Prasugrel—Headache—Cyclosporine—psoriasis	0.000142	0.000899	CcSEcCtD
Prasugrel—Anaemia—Methotrexate—psoriasis	0.000142	0.000899	CcSEcCtD
Prasugrel—Hypersensitivity—Triamcinolone—psoriasis	0.00014	0.000885	CcSEcCtD
Prasugrel—Rash—Mycophenolate mofetil—psoriasis	0.00014	0.000883	CcSEcCtD
Prasugrel—Dermatitis—Mycophenolate mofetil—psoriasis	0.00014	0.000882	CcSEcCtD
Prasugrel—Headache—Mycophenolate mofetil—psoriasis	0.000139	0.000877	CcSEcCtD
Prasugrel—Diarrhoea—Hydrocortisone—psoriasis	0.000138	0.000873	CcSEcCtD
Prasugrel—Leukopenia—Methotrexate—psoriasis	0.000138	0.00087	CcSEcCtD
Prasugrel—Dizziness—Prednisolone—psoriasis	0.000137	0.000864	CcSEcCtD
Prasugrel—Asthenia—Triamcinolone—psoriasis	0.000136	0.000862	CcSEcCtD
Prasugrel—Body temperature increased—Betamethasone—psoriasis	0.000136	0.000862	CcSEcCtD
Prasugrel—Body temperature increased—Dexamethasone—psoriasis	0.000136	0.000862	CcSEcCtD
Prasugrel—Nausea—Cyclosporine—psoriasis	0.000135	0.000853	CcSEcCtD
Prasugrel—Cough—Methotrexate—psoriasis	0.000134	0.000848	CcSEcCtD
Prasugrel—P2RY12—GPCR ligand binding—CCL20—psoriasis	0.000134	0.00821	CbGpPWpGaD
Prasugrel—Dizziness—Hydrocortisone—psoriasis	0.000133	0.000844	CcSEcCtD
Prasugrel—P2RY12—Signaling by GPCR—HCAR2—psoriasis	0.000132	0.00811	CbGpPWpGaD
Prasugrel—Nausea—Mycophenolate mofetil—psoriasis	0.000132	0.000832	CcSEcCtD
Prasugrel—Rash—Prednisolone—psoriasis	0.00013	0.000824	CcSEcCtD
Prasugrel—Dermatitis—Prednisolone—psoriasis	0.00013	0.000823	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	0.00013	0.000822	CcSEcCtD
Prasugrel—Fatigue—Prednisone—psoriasis	0.000129	0.000818	CcSEcCtD
Prasugrel—Headache—Prednisolone—psoriasis	0.000129	0.000818	CcSEcCtD
Prasugrel—Rash—Hydrocortisone—psoriasis	0.000127	0.000805	CcSEcCtD
Prasugrel—Dermatitis—Hydrocortisone—psoriasis	0.000127	0.000804	CcSEcCtD
Prasugrel—Headache—Hydrocortisone—psoriasis	0.000126	0.000799	CcSEcCtD
Prasugrel—Dizziness—Triamcinolone—psoriasis	0.000126	0.000794	CcSEcCtD
Prasugrel—Anaphylactic shock—Methotrexate—psoriasis	0.000126	0.000793	CcSEcCtD
Prasugrel—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000124	0.00764	CbGpPWpGaD
Prasugrel—Asthenia—Dexamethasone—psoriasis	0.000124	0.000782	CcSEcCtD
Prasugrel—Asthenia—Betamethasone—psoriasis	0.000124	0.000782	CcSEcCtD
Prasugrel—Thrombocytopenia—Methotrexate—psoriasis	0.000123	0.000777	CcSEcCtD
Prasugrel—Nausea—Prednisolone—psoriasis	0.000123	0.000776	CcSEcCtD
Prasugrel—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000123	0.00754	CbGpPWpGaD
Prasugrel—Skin disorder—Methotrexate—psoriasis	0.000122	0.000771	CcSEcCtD
Prasugrel—Nausea—Hydrocortisone—psoriasis	0.00012	0.000758	CcSEcCtD
Prasugrel—Rash—Triamcinolone—psoriasis	0.00012	0.000758	CcSEcCtD
Prasugrel—Dermatitis—Triamcinolone—psoriasis	0.00012	0.000757	CcSEcCtD
Prasugrel—Headache—Triamcinolone—psoriasis	0.000119	0.000753	CcSEcCtD
Prasugrel—Body temperature increased—Prednisone—psoriasis	0.000119	0.00075	CcSEcCtD
Prasugrel—Diarrhoea—Dexamethasone—psoriasis	0.000118	0.000746	CcSEcCtD
Prasugrel—Diarrhoea—Betamethasone—psoriasis	0.000118	0.000746	CcSEcCtD
Prasugrel—Hypotension—Methotrexate—psoriasis	0.000117	0.000741	CcSEcCtD
Prasugrel—ALB—Lipoprotein metabolism—APOE—psoriasis	0.000115	0.0071	CbGpPWpGaD
Prasugrel—Dizziness—Dexamethasone—psoriasis	0.000114	0.000721	CcSEcCtD
Prasugrel—Dizziness—Betamethasone—psoriasis	0.000114	0.000721	CcSEcCtD
Prasugrel—Nausea—Triamcinolone—psoriasis	0.000113	0.000714	CcSEcCtD
Prasugrel—Dyspnoea—Methotrexate—psoriasis	0.000112	0.000707	CcSEcCtD
Prasugrel—Hypersensitivity—Prednisone—psoriasis	0.000111	0.000699	CcSEcCtD
Prasugrel—P2RY12—Hemostasis—ITGAL—psoriasis	0.00011	0.00677	CbGpPWpGaD
Prasugrel—CYP2C19—Biological oxidations—CYP2S1—psoriasis	0.00011	0.00675	CbGpPWpGaD
Prasugrel—Rash—Betamethasone—psoriasis	0.000109	0.000687	CcSEcCtD
Prasugrel—Rash—Dexamethasone—psoriasis	0.000109	0.000687	CcSEcCtD
Prasugrel—Dermatitis—Betamethasone—psoriasis	0.000109	0.000687	CcSEcCtD
Prasugrel—Dermatitis—Dexamethasone—psoriasis	0.000109	0.000687	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Methotrexate—psoriasis	0.000108	0.000685	CcSEcCtD
Prasugrel—CYP2C19—Metapathway biotransformation—CYP2S1—psoriasis	0.000108	0.00666	CbGpPWpGaD
Prasugrel—Fatigue—Methotrexate—psoriasis	0.000108	0.000684	CcSEcCtD
Prasugrel—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000108	0.00664	CbGpPWpGaD
Prasugrel—Headache—Dexamethasone—psoriasis	0.000108	0.000683	CcSEcCtD
Prasugrel—Headache—Betamethasone—psoriasis	0.000108	0.000683	CcSEcCtD
Prasugrel—Asthenia—Prednisone—psoriasis	0.000108	0.000681	CcSEcCtD
Prasugrel—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000107	0.00657	CbGpPWpGaD
Prasugrel—CYP2C19—Melatonin metabolism and effects—APOE—psoriasis	0.000106	0.00655	CbGpPWpGaD
Prasugrel—Diarrhoea—Prednisone—psoriasis	0.000103	0.00065	CcSEcCtD
Prasugrel—Nausea—Betamethasone—psoriasis	0.000102	0.000648	CcSEcCtD
Prasugrel—Nausea—Dexamethasone—psoriasis	0.000102	0.000648	CcSEcCtD
Prasugrel—CYP2C9—Biological oxidations—CYP2S1—psoriasis	0.0001	0.00616	CbGpPWpGaD
Prasugrel—Dizziness—Prednisone—psoriasis	9.93e-05	0.000628	CcSEcCtD
Prasugrel—Body temperature increased—Methotrexate—psoriasis	9.92e-05	0.000627	CcSEcCtD
Prasugrel—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	9.87e-05	0.00607	CbGpPWpGaD
Prasugrel—Rash—Prednisone—psoriasis	9.47e-05	0.000599	CcSEcCtD
Prasugrel—Dermatitis—Prednisone—psoriasis	9.46e-05	0.000598	CcSEcCtD
Prasugrel—ALB—Hemostasis—SERPINB8—psoriasis	9.42e-05	0.00579	CbGpPWpGaD
Prasugrel—Headache—Prednisone—psoriasis	9.41e-05	0.000595	CcSEcCtD
Prasugrel—Hypersensitivity—Methotrexate—psoriasis	9.25e-05	0.000585	CcSEcCtD
Prasugrel—Asthenia—Methotrexate—psoriasis	9e-05	0.000569	CcSEcCtD
Prasugrel—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—psoriasis	8.99e-05	0.00553	CbGpPWpGaD
Prasugrel—Nausea—Prednisone—psoriasis	8.92e-05	0.000564	CcSEcCtD
Prasugrel—Diarrhoea—Methotrexate—psoriasis	8.59e-05	0.000543	CcSEcCtD
Prasugrel—Dizziness—Methotrexate—psoriasis	8.3e-05	0.000525	CcSEcCtD
Prasugrel—Rash—Methotrexate—psoriasis	7.91e-05	0.0005	CcSEcCtD
Prasugrel—Dermatitis—Methotrexate—psoriasis	7.91e-05	0.0005	CcSEcCtD
Prasugrel—ALB—Folate Metabolism—CAT—psoriasis	7.91e-05	0.00486	CbGpPWpGaD
Prasugrel—Headache—Methotrexate—psoriasis	7.86e-05	0.000497	CcSEcCtD
Prasugrel—P2RY12—Signaling Pathways—HCAR2—psoriasis	7.79e-05	0.00479	CbGpPWpGaD
Prasugrel—ALB—Vitamin B12 Metabolism—CRP—psoriasis	7.71e-05	0.00474	CbGpPWpGaD
Prasugrel—ALB—Lipid and lipoprotein metabolism—APOE—psoriasis	7.67e-05	0.00472	CbGpPWpGaD
Prasugrel—ALB—Vitamin B12 Metabolism—APOE—psoriasis	7.55e-05	0.00464	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—CCL20—psoriasis	7.54e-05	0.00464	CbGpPWpGaD
Prasugrel—Nausea—Methotrexate—psoriasis	7.45e-05	0.000471	CcSEcCtD
Prasugrel—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	7.45e-05	0.00458	CbGpPWpGaD
Prasugrel—ALB—Folate Metabolism—IL4—psoriasis	7.26e-05	0.00447	CbGpPWpGaD
Prasugrel—ALB—Vitamin B12 Metabolism—ICAM1—psoriasis	7.09e-05	0.00436	CbGpPWpGaD
Prasugrel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	7.04e-05	0.00433	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—CCL20—psoriasis	6.85e-05	0.00421	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—TAGAP—psoriasis	6.76e-05	0.00415	CbGpPWpGaD
Prasugrel—CYP3A4—Biological oxidations—CYP2S1—psoriasis	6.6e-05	0.00406	CbGpPWpGaD
Prasugrel—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	6.51e-05	0.004	CbGpPWpGaD
Prasugrel—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	6.33e-05	0.00389	CbGpPWpGaD
Prasugrel—ALB—Selenium Micronutrient Network—CAT—psoriasis	6.28e-05	0.00386	CbGpPWpGaD
Prasugrel—ALB—Folate Metabolism—CRP—psoriasis	6.28e-05	0.00386	CbGpPWpGaD
Prasugrel—P2RY12—G alpha (i) signalling events—CXCL8—psoriasis	5.95e-05	0.00366	CbGpPWpGaD
Prasugrel—ALB—Folate Metabolism—ICAM1—psoriasis	5.77e-05	0.00355	CbGpPWpGaD
Prasugrel—CYP3A4—Tryptophan metabolism—CAT—psoriasis	5.7e-05	0.0035	CbGpPWpGaD
Prasugrel—ALB—Vitamin B12 Metabolism—IFNG—psoriasis	5.4e-05	0.00332	CbGpPWpGaD
Prasugrel—P2RY12—Platelet activation, signaling and aggregation—VEGFA—psoriasis	5.08e-05	0.00312	CbGpPWpGaD
Prasugrel—ALB—Selenium Micronutrient Network—CRP—psoriasis	4.99e-05	0.00307	CbGpPWpGaD
Prasugrel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	4.91e-05	0.00302	CbGpPWpGaD
Prasugrel—P2RY12—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	4.73e-05	0.00291	CbGpPWpGaD
Prasugrel—ALB—Selenium Micronutrient Network—ICAM1—psoriasis	4.58e-05	0.00282	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—NOS2—psoriasis	4.52e-05	0.00278	CbGpPWpGaD
Prasugrel—ALB—SLC-mediated transmembrane transport—CP—psoriasis	4.5e-05	0.00277	CbGpPWpGaD
Prasugrel—ALB—Vitamin B12 Metabolism—NFKB1—psoriasis	4.49e-05	0.00276	CbGpPWpGaD
Prasugrel—ALB—Folate Metabolism—IFNG—psoriasis	4.39e-05	0.0027	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CCL20—psoriasis	4.05e-05	0.00249	CbGpPWpGaD
Prasugrel—ALB—Folate Metabolism—NFKB1—psoriasis	3.65e-05	0.00225	CbGpPWpGaD
Prasugrel—P2RY12—GPCR ligand binding—CXCL8—psoriasis	3.61e-05	0.00222	CbGpPWpGaD
Prasugrel—ALB—Vitamin B12 Metabolism—TNF—psoriasis	3.49e-05	0.00215	CbGpPWpGaD
Prasugrel—ALB—Selenium Micronutrient Network—IFNG—psoriasis	3.49e-05	0.00214	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—NDUFA5—psoriasis	2.92e-05	0.0018	CbGpPWpGaD
Prasugrel—ALB—Selenium Micronutrient Network—NFKB1—psoriasis	2.9e-05	0.00178	CbGpPWpGaD
Prasugrel—ALB—Platelet degranulation—VEGFA—psoriasis	2.84e-05	0.00175	CbGpPWpGaD
Prasugrel—ALB—Folate Metabolism—TNF—psoriasis	2.84e-05	0.00175	CbGpPWpGaD
Prasugrel—ALB—Vitamin B12 Metabolism—IL6—psoriasis	2.82e-05	0.00173	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—ITGAL—psoriasis	2.73e-05	0.00168	CbGpPWpGaD
Prasugrel—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—psoriasis	2.71e-05	0.00167	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—VEGFA—psoriasis	2.62e-05	0.00161	CbGpPWpGaD
Prasugrel—ALB—Folate Metabolism—TP53—psoriasis	2.51e-05	0.00154	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—CYP2S1—psoriasis	2.48e-05	0.00153	CbGpPWpGaD
Prasugrel—ALB—Metabolism—NDUFA5—psoriasis	2.46e-05	0.00151	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.29e-05	0.00141	CbGpPWpGaD
Prasugrel—ALB—Folate Metabolism—IL6—psoriasis	2.29e-05	0.00141	CbGpPWpGaD
Prasugrel—ALB—Transmembrane transport of small molecules—CP—psoriasis	2.29e-05	0.00141	CbGpPWpGaD
Prasugrel—ALB—Selenium Micronutrient Network—TNF—psoriasis	2.26e-05	0.00139	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—SOCS1—psoriasis	2.23e-05	0.00137	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—NDUFA5—psoriasis	2.21e-05	0.00136	CbGpPWpGaD
Prasugrel—ALB—Transmembrane transport of small molecules—CARM1—psoriasis	2.18e-05	0.00134	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—TYK2—psoriasis	2.12e-05	0.00131	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CYP2S1—psoriasis	2.09e-05	0.00129	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.06e-05	0.00127	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—CXCL8—psoriasis	2.04e-05	0.00125	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—NDUFA5—psoriasis	2.01e-05	0.00124	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—TP53—psoriasis	1.98e-05	0.00122	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CYP2S1—psoriasis	1.88e-05	0.00115	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.88e-05	0.00115	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—CXCL8—psoriasis	1.85e-05	0.00114	CbGpPWpGaD
Prasugrel—ALB—Selenium Micronutrient Network—IL6—psoriasis	1.82e-05	0.00112	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CYP2S1—psoriasis	1.71e-05	0.00105	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—LEP—psoriasis	1.64e-05	0.00101	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—APOE—psoriasis	1.64e-05	0.00101	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—NFKBIA—psoriasis	1.53e-05	0.000942	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—NDUFA5—psoriasis	1.33e-05	0.000817	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—VEGFA—psoriasis	1.26e-05	0.000775	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—TYK2—psoriasis	1.26e-05	0.000772	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—CARM1—psoriasis	1.21e-05	0.000746	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CYP2S1—psoriasis	1.13e-05	0.000694	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—NOS2—psoriasis	1.12e-05	0.00069	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.1e-05	0.000674	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CXCL8—psoriasis	1.09e-05	0.000672	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—IL6—psoriasis	1.04e-05	0.000639	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CARM1—psoriasis	1.02e-05	0.000628	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—JUN—psoriasis	1.02e-05	0.000625	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	9.84e-06	0.000605	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—NFKB1—psoriasis	9.78e-06	0.000601	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—PPARG—psoriasis	9.55e-06	0.000587	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CARM1—psoriasis	9.17e-06	0.000564	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	8.97e-06	0.000552	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—VEGFA—psoriasis	8.88e-06	0.000546	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—STAT3—psoriasis	8.79e-06	0.00054	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	8.57e-06	0.000527	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CARM1—psoriasis	8.36e-06	0.000514	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	7.82e-06	0.000481	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—CAT—psoriasis	7.46e-06	0.000459	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—TP53—psoriasis	6.71e-06	0.000412	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—VEGFA—psoriasis	6.5e-06	0.0004	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CAT—psoriasis	6.28e-06	0.000386	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—IL6—psoriasis	6.14e-06	0.000377	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—APOE—psoriasis	5.8e-06	0.000357	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CAT—psoriasis	5.64e-06	0.000347	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CARM1—psoriasis	5.51e-06	0.000339	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CAT—psoriasis	5.14e-06	0.000316	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PPARG—psoriasis	5.05e-06	0.000311	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—TP53—psoriasis	4.91e-06	0.000302	CbGpPWpGaD
Prasugrel—ALB—Metabolism—APOE—psoriasis	4.88e-06	0.0003	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—APOE—psoriasis	4.38e-06	0.000269	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PPARG—psoriasis	4.25e-06	0.000261	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—APOE—psoriasis	4e-06	0.000246	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PPARG—psoriasis	3.82e-06	0.000235	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PPARG—psoriasis	3.48e-06	0.000214	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CAT—psoriasis	3.39e-06	0.000209	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—APOE—psoriasis	2.64e-06	0.000162	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PPARG—psoriasis	2.3e-06	0.000141	CbGpPWpGaD
